Tariq Arshad's most recent trade in Qualigen Therapeutics Inc was a trade of 102,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 11, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics Inc | Tariq Arshad | SVP/Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 102,000 | 102,000 | - | - | Stock Option (Right to Buy) | |
| Qualigen Therapeutics Inc | Tariq Arshad | SVP/Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Qualigen Therapeutics Inc | Tariq Arshad | SVP/Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |